Pakistan

in page functions
[French]
Pakistan
Total population (2017) 196,743,438
Birth cohort (2017) 5,482,345
Surviving Infants (surviving to 1 year per year, 2017) 5,131,327
Infant mortality rate (deaths < 1 year per 1000 births, 2015) 66/1000
Child mortality rate (deaths < 5 years per 1000 births, 2015) 81/1000
World Bank Index, IDA (2015) 3.22
Gross Nation Income (per capita US$, 2015) 1,440
Co-financing group (2017) Preparatory transition
No. of districts/territories (2015) 147

Contact Gavi

For more info, contact Gavi country representative officer or email here

Gavi support for Pakistan

Type of support

Approvals

2001-2021 (US$)
(23 May 2017)

Commitments

2001-2021 (US$)
(23 May 2017)

Disbursements

2000-2017 (US$)
(23 May 2017)

% Disbursed

(23 May 2017)
2001 2002 2003 2004 2005 2006 2007 2008 2009 2010 2011 2012 2013 2014 2015 2016 2017 2018
Total $1,006,280,423 $1,124,936,923 $985,353,273
Civil Society Organisation support (CSO) $7,656,073 $7,656,073 $7,738,649 101%
Health system strengthening (HSS 1) $23,524,500 $23,524,500 $23,524,500 100%
Health system strengthening (HSS 2) $59,000,000 $84,000,000 $34,000,000 58%
HepB mono (NVS) $24,953,324 $24,953,324 $24,953,324 100%
Immunisation services support (ISS) $48,763,740 $48,763,740 $48,763,740 100%
Injection Safety Devices (NVS) $1,702,500 $3,100,000 $1,972,240 116%
Injection safety support (INS) $7,405,082 $7,405,082 $7,405,082 100%
IPV (NVS) $11,271,043 $11,271,043 $8,509,560 75%
Measles SIA (NVS) $10,029,548 $10,029,548 $10,029,548 100%
Measles SIA - Operational costs (OPC) $21,664,500 $21,664,500 $21,664,500 100%
Penta (NVS) $352,875,914 $377,433,914 $362,825,656 103%
Pneumo (NVS) $367,573,418 $415,407,918 $387,067,412 105%
Rotavirus (NVS) $22,856,500 $42,723,000 $5,339,934 23%
Tetra DTP-HepB (NVS) $31,387,734 $31,387,734 $31,387,734 100%
Vaccine Introduction Grant (VIG) $15,616,547 $15,616,547 $10,171,394 65%

Red line on table indicates duration of support based on commitments.
Commitments: Multi-year programme budgets endorsed in principle by the Gavi Board. These become financial commitments upon approval each year for the following calendar year.
Approvals: Total Approved for funding

Download data for commitments, approvals & disbursements in XLS format

Pakistan DTP3 / immunisation coverage

DTP3 - WHO/UNICEF estimates (2015)

Grade of confidence


N/A
DTP3 - Official country estimates (2015) 75%
M:F sex ratio at birth (2017) 1.09
Household survey: DTP3 coverage for male (2012) 67.20%
Household survey: DTP3 coverage for female (2012) 63.10%
Household survey: Last DTP3 survey (2012) 78%
% districts achieving > 80% DTP3 coverage (2015) 59%
% districts achieving < 50% DTP3 coverage (2015) 14%
MCV WHO/UNICEF estimates (2015) 61%

Breakdown of support

Non-vaccine support Vaccine support
16% 84%
$153,267,865 $832,085,408

Data refers to disbursed values, date as per above chart

Move mouse over graph for details

News and updates relating to Pakistan

21 June 2017

Gavi Board meeting, 14-15 June 2017

The Gavi Board meeting was held in Geneva, Switzerland on 14-15 June 2017.

15 June 2017

DRC: a nurse vaccinates a child

Gavi to help protect millions more children against polio

Gavi Board agrees to extend support for inactivated polio vaccine (IPV) to 2020; new policy on fragile settings, emergencies and refugees also approved.

13 January 2017

Punjab, Pakistan: first baby to be vaccinated with the rotavirus vaccine

Punjab pioneers protect children from deadly diarrhoea

Rotavirus vaccine introduction paves the way for national roll-out in Pakistan.

close icon

modal window here